Form 4: Cardlytics Director Liane Hornsey Acquires Restricted Stock Units

Director Liane Hornsey acquired 1,326 restricted stock units (RSUs) of Cardlytics, Inc. on April 9, 2024, which will vest in full on the one-year anniversary of the grant date.

Summary

• On April 9, 2024, Liane Hornsey, a director of Cardlytics, Inc., acquired 1,326 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on April 9, 2025, provided Hornsey remains a director of Cardlytics on that date.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of an RSU grant, which is a common form of compensation. It doesn't necessarily indicate a positive or negative outlook for the company.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent on the reporting person remaining a director of the issuer.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of RSUs aligns the director's interests with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.

Key Dates